| Vaccine-Related Journal
Articles |
 |
| Diseases and Vaccines |
|
Long-Term Persistence of Antibodies after
One or Two Doses of MMR-Vaccine
Authors: Vandermeulen C, Mathieu R, Geert LR, Pierre VD, Karel H
Source: Vaccine, September 17, 2007; 25(37-38):6672-6676 |
|
| Abstract |
Fetal Risk Associated With Rubella Vaccination
During Pregnancy
Authors: Badilla X, Morice A, Avila-Aguero ML, et al
Source: Pediatr Infect Dis J, September 2007; 26:830-835 |
|
| Abstract |
Safety and Immunogenicity of Early
Vaccination with Two Doses of Tetravalent Measles-Mumps-Rubella-Varicella
(MMRV) Vaccine in Healthy Children From
9 Months of Age
Authors: Goh P, Lim FS, Han HH, Willems P
Source: Infection, August 2007 [Epub ahead of print] |
|
| Abstract |
Notice to Readers: Update of Recommended
Nomenclature for the Genetic
Characteristics of Wild-Type Rubella Viruses
Source: MMWR, June 15, 2007; 56(23):582 |
|
| HTML | PDF
(entire issue) |
Congenital Rubella Syndrome in a Child
Born to Liberian Refugees: Clinical and Public Health Perspectives
Authors: Plotinsky RN, Talbot EA, Kellenberg JE, et al
Source: Clin Pediatr (Phila), May 2007; 46(4):349-355 |
|
| Abstract |
Reducing Global Disease Burden of
Measles and Rubella: Report of the WHO Steering Committee on Research
Related to Measles and Rubella Vaccines and Vaccination, 2005
Authors: Muller CP, Kremer JR, Best JM, et al
Source: Vaccine, January 2, 2007; 25(1):1-9 |
|
|
Abstract |
General Recommendations on Immunization
Source: MMWR, December 1, 2006; 55(RR-15):1-48 |
|
| HTML | PDF
(entire issue) |
The History of Rubella and Rubella
Vaccination Leading to Elimination
Author: Plotkin SA
Source: Clin Infect Dis, November 1, 2006, Vol. 43(Suppl 3):S164-168 |
|
| Abstract |
The Evidence for the Elimination of
Rubella and Congenital Rubella Syndrome in the United States: A
Public Health Achievement
Authors: Reef SE, Cocchi SL
Source: Clin Infect Dis, November 1, 2006, Vol. 43(Suppl 3):S123-125 |
|
| Abstract |
The Epidemiological Profile of Rubella
and Congenital Rubella Syndrome in the United States, 1998-2004:
The Evidence for Absence of Endemic Transmission
Authors: Reef SE, Redd SB, Abernathy E, Zimmerman L, Icenogle JP
Source: Clin Infect Dis, November 1, 2006, Vol. 43(Suppl 3):S126-132 |
|
| Abstract |
Has the United States Population Been
Adequately Vaccinated to Achieve Rubella Elimination?
Authors: Bloom S, Smith P, Stanwyck C, Stokley S
Source: Clin Infect Dis, November 1, 2006, Vol. 43(Suppl 3):S141-145 |
|
| Abstract |
Evaluation of Potentially Common Adverse
Events Associated with the First and Second Doses of Measles-Mumps-Rubella
Vaccine
Authors: Lebaron CW, Bi D, Sullivan BJ, Beck C, Gargiullo P
Source: Pediatrics, October 2006, Vol. 118(4):1422-1430 |
|
| Abstract |
Has the Measles-Mumps-Rubella Vaccine
Been Fully Exonerated? (Commentary)
Author: Katz SL
Source: Pediatrics, October 2006, Vol. 118(4):1744-1745 |
|
| Abstract |
No Evidence of Persisting Measles
Virus in Peripheral Blood Mononuclear Cells from Children with Autism
Spectrum Disorder
Authors: D'Souza Y, Fombonne E, Ward BJ
Source: Pediatrics, October 2006, Vol. 118(4):1664-1675 |
|
| Abstract |
A Combination Measles, Mumps, Rubella,
and Varicella Vaccine (ProQuad) Given to 4- to 6-Year-old Healthy
Children Vaccinated Previously with M-M-RII and Varivax
Authors: Reisinger KS, Brown ML, Xu J, et al
Source: Pediatrics, Feb. 2006, Vol. 117(2):265-272 |
|
| Abstract |
Low Postpartum Vaccination Rates in
High-Risk Women, Miami, Florida, 2001
Authors: Bloom SA, Trepka, MJ, Nobles RE, Becerra MA, Reef S, Zhang G
Source: Am J Prev Med, February 2006, Vol. 30(2):119-124 |
|
| Abstract |
Immunogenicity and Safety of Two Doses
of Tetravalent Measles-Mumps-Rubella-Varicella Vaccine in Healthy
Children
Authors: Knuf M, Habermehl P, Zepp F, et al
Source: Pediatr Infect Dis J, January 2006, Vol. 25(1):12-18 |
|
| Abstract |
Evaluation of a Quadrivalent Measles,
Mumps, Rubella and Varicella Vaccine in Healthy Children
Authors: Shinefield H, Black S, Digilio L, et al
Source: Pediatr Infect Dis J, August 2005, Vol. 24(8):665-669 |
|
| Abstract |
Dose-Response Study of a Quadrivalent
Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children
Authors: Shinefield H, Williams WR, Marchant C, et al
Source: Pediatr Infect Dis J, August 2005, Vol. 24(8):670-675 |
|
| Abstract |
Assessment of Pernatal Hepatitis B
and Rubella Prevention in New Hampshire Delivery Hospitals
Authors: Bascom S, Miller S, Greenblatt J
Source: Pediatrics, May 5, 2005, Vol. 115(5):e594-9 |
|
| HTML |
Achievements in Public Health: Elimination
of Rubella and Congenital Rubella Syndrome --- United States, 1969--2004
Source: MMWR, March 25, 2005, Vol. 54(11):279-282 |
|
| HTML |
Progress Toward Elimination of Measles
and Prevention of Congenital Rubella Infection --- European
Region, 1990--2004
Source: MMWR, February 25, 2005, Vol. 54(07):175-178 |
|
| HTML |
MMR Vaccination and Pervasive Developmental
Disorders: A Case-Control Study
Authors: Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith
PG, Hall AJ
Source: Lancet, September 11, 2004, Vol. 364(9438):963-9 |
|
| Abstract |
Relationship Between MMR Vaccine and
Autism
Authors: Klein KC, Diehl EB
Source: The Annals of Pharmacotherapy, July-August 2004, Vol. 38(7-8):1297-1300 |
|
| Abstract |
MMR Vaccination and Febrile Seizures
Authors: Vestergaard M, Hviid A, Meldgaard Madsen K, et al.
Source: JAMA, July 21, 2004, Vol. 292(3):351-7 |
|
| Abstract |
Immunization Safety Review: Vaccines
and Autism
Source: Institute of Medicine (IOM) |
|
| HTML |
An Economic Analysis of the Current
Universal 2-Dose Measles-Mumps-Rubella Vaccination Program in the
United States
Authors: Zhou F, Reef S, Massoudi M, et al
Source: J Infect Dis, May 1, 2004, Vol. 189(Suppl 1):S131-S145 |
|
| Abstract |
Progress Towards Measles Elimination,
Western Hemisphere, 2002-2003
Source: Weekly Epidemiological Record, April 9, 2004, Vol.79(15):149-151 |
|
| PDF |
Rubella
Authors: Banatvala JE, Brown DWG
Source: Lancet, April 3, 2004, Vol. 363(9415):1127-1137 |
|
| Abstract |
Measles Vaccines
Source: Weekly Epidemiological Record, April 2, 2004, Vol.79(14):130-142 |
|
| PDF |
Retraction of an Interpretation
Source: The Lancet, March 6, 2004, Vol. 363(9411)
You must
register (no charge) to access this article. |
|
| HTML |
The Lessons of MMR
Source: The Lancet, March 6, 2004, Vol. 363(9411)
You must
register (no charge) to access this article. |
|
| HTML |
Measles, Mumps and Rubella--Safety
of the Combined Vaccine
Author: Bedford H
Source: Nurs Times, March 2-8, 2004, Vol. 100(9):74-75 |
|
| Abstract |
A Statement by the Editors of the
Lancet
Source: The Lancet, February 28, 2004 |
|
| PDF |
MMR Vaccine and Autism: An Update
of the Scientific Evidence
Authors: DeStefano F, Thompson WW
Source: Expert Review of Vaccines, February 2004, Vol. 3(1):19-22 |
|
| Abstract |
Can Measles Be Eradicated Globally?
Author: De Quadros CA
Source: Bulletin of the World Health Organization, Feb. 2004, Vol.82(2):134-138 |
|
| PDF |
Age at First Measles-Mumps-Rubella
Vaccination in Children with Autism and School-Matched Control Subjects:
A Population-Based Study in Metropolitan Atlanta
Authors: DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle
C
Source: Pediatrics, February 2004, Vol. 113(2):259-266 |
|
| Abstract |
MMR Vaccination and Autism: What Is
the Evidence for a Causal Association?
Authors: Madsen KM, Vestergaard M
Source: Drug Safety, 2004, Vol. 27(12):831-840 |
|
| Abstract |
Rubella
journal articles 2003-1996
|
IAC Home